...
首页> 外文期刊>Journal of mass spectrometry: JMS >Characterization of the volatile profile of Antarctic bacteria by using solid-phase microextraction-gas chromatography-mass spectrometry
【24h】

Characterization of the volatile profile of Antarctic bacteria by using solid-phase microextraction-gas chromatography-mass spectrometry

机译:固相微萃取-气相色谱-质谱法表征南极细菌的挥发性特征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Bacteria belonging to the Burkholderia cepacia complex (Bcc) are significant pathogens in Cystic Fibrosis (CF) patients and are resistant to a plethora of antibiotics. In this context, microorganisms from Antarctica are interesting because they produce antimicrobial compounds inhibiting the growth of other bacteria. This is particularly true for bacteria isolated from Antarctic sponges. The aim of this work was to characterize a set of Antarctic bacteria for their ability to produce new natural drugs that could be exploited in the control of infections in CF patients by Bcc bacteria. Hence, 11 bacterial strains allocated to different genera (e.g., Pseudoalteromonas, Arthrobacter and Psychrobacter) were tested for their ability to inhibit the growth of 21 Bcc strains and some other human pathogens. All these bacteria completely inhibited the growth of most, if not all, Bcc strains, suggesting a highly specific activity toward Bcc strains. Experimental evidences showed that the antimicrobial compounds are small volatile organic compounds, and are constitutively produced via an unknown pathway. The microbial volatile profile was obtained by SPME-GC-MS within the m/z interval of 40-450. Solid phase micro extraction technique affords the possibility to extract the volatile compounds in head space with a minimal sample perturbation. Principal component analysis and successive cluster discriminant analysis was applied to evaluate the relationships among the volatile organic compounds with the aim of classifying the microorganisms by their volatile profile. These data highlight the potentiality of Antarctic bacteria as novel sources of antibacterial substances to face Bcc infections in CF patients.
机译:洋葱伯克霍尔德菌复合体(Bcc)的细菌是囊性纤维化(CF)患者的重要病原体,对多种抗生素具有抗药性。在这方面,来自南极洲的微生物是令人感兴趣的,因为它们产生抑制其他细菌生长的抗微生物化合物。从南极海绵中分离出的细菌尤其如此。这项工作的目的是对一组南极细菌产生新天然药物的能力进行表征,这些新天然药物可用于控制Bcc细菌对CF患者的感染。因此,测试了分配给不同属的11种细菌菌株(例如,假单胞菌属,节杆菌和精神细菌)抑制21种Bcc菌株和一些其他人类病原体生长的能力。所有这些细菌完全抑制了大多数(如果不是全部)Bcc菌株的生长,表明对Bcc菌株具有高度特异性。实验证据表明,抗菌化合物是小的挥发性有机化合物,并且是通过未知途径组成性产生的。通过SPME-GC-MS在40-450的m / z间隔内获得了微生物挥发性分布图。固相微萃取技术提供了以最小的样品扰动在顶部空间萃取挥发性化合物的可能性。应用主成分分析和连续聚类判别分析来评估挥发性有机化合物之间的关系,目的是通过微生物的挥发性特征对其进行分类。这些数据突显了南极细菌作为新型抗菌物质来源的潜力,可应对CF患者的Bcc感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号